#ESSB2024
Very exciting approaches for Spatial Biology at #ESSB2024 in Berlin
#SpatialOmics #SpatialBiology #Omics
December 12, 2024 at 10:19 AM
Mind blowing science with 10x @10xgenomics.bsky.social #ESSB2024
December 12, 2024 at 12:09 PM
Day 2 #ESSB2024
Aysegül Adam from the lab of Anja Hauser presents multiplex histology data showing activated ILC1 localisation in human periodontitis and their fibrovascular niches.
December 13, 2024 at 9:36 AM
The inaugural conference of the European Society for Spatial Biology (ESSB) kicked off in Berlin today! 🚀
Fantastic talks and a great opportunity to connect with others in the spatial omics community. #SpatialOmics #ESSB2024 #SpatialBiology #Omics
December 12, 2024 at 9:07 AM
Iva Buljan from the lab of @afrendeiro.bsky.social presents the analysis of Genotype-Tissue Expression Project deriving tissue age indicators and identifying interesting mismatches between tissue and chronological age
Preprint: www.biorxiv.org/content/10.1...
#ESSB2024
Tissue clocks derived from histological signatures of biological aging enable tissue-specific aging predictions from blood
Aging, the predominant risk factor for numerous diseases, manifests in various forms across the structure and architecture of tissues of the human body, offering the opportunity to quantify and interp...
www.biorxiv.org
December 12, 2024 at 3:20 PM
Harshan Singh Bhati showing how completely cleared DISCO mice and human organs can be used to identify unrecognized metastases and to combine with mass spectrometry for 3D targeted proteomics. #ESSB2024
see www.cell.com/cell/fulltex...
December 13, 2024 at 10:24 AM
Bernd Bodenmiller showcasing new technologies for spatial proteomics including tapping into the synchrotron for X-ray based imaging (www.nature.com/articles/s41...) and their impressive efforts to bring advanced spatial technologies into clinical care (www.cell.com/cancer-cell/... )
#ESSB2024
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support
The application and integration of molecular profiling technologies create novel opportunities for personalized medicine. Here, we introduce the Tumor Profiler Study, an observational trial combining a prospective diagnostic approach to assess the relevance of in-depth tumor profiling to support clinical decision-making with an exploratory approach to improve the biological understanding of the disease.
www.cell.com
December 12, 2024 at 4:01 PM